Metal-organic frameworks with exceptionally large pore aperatures
The disclosure relates to metal organic frameworks or isoreticular metal organic frameworks, methods of production thereof, and methods of use thereof.
1. A MOF or IRMOF comprising the general structure M-L-M, wherein M comprises a metal and L is a linking moiety of Formula I:
wherein,
A 1 -A 8 are independently either N or C;
X 1 and X 2 are functional groups (FG);
R 1 and R 10 are hydroxyls;
R 2 -R 5 , R 7 , R 9 ,R 11 and R 12 are hydrogen;
R 6 and R 8 are selected from the group consisting of (C 1 -C 12 )alkyl, (C 1 -C 12 )alkenyl, substituted (C 1 -C 12 )alkenyl, (C 1 -C 12 )alkynyl, substituted (C 1 -C 12 )alkynyl, hetero-(C 1 -C 12 )alkyl, substituted hetero-(C 1 -C 12 )alkyl, hetero-(C 1 -C 12 )alkenyl, substituted hetero-(C 1 -C 12 )alkenyl, hetero-(C 1 -C 12 )alkynyl, and substituted hetero-(C 1 -C 12 )alkynyl;
z is a number from 1 to 20; and
with the proviso that R is absent when bound to an A that is N.
2. The MOF or IRMOF of claim 1 , wherein M is either a transition metal or an alkaline earth metal.
3. The MOF or IRMOF of claim 1 , wherein M is either Mg or Zn.
4. The MOF or IRMOF of claim 3 , wherein X 1 and X 2 are carboxylic acids.
5. The MOF or IRMOF of claim 4 , wherein A 1 -A 8 are C.
6. The MOF or IRMOF of claim 1 , wherein
R 6 and R 8 are (C 1 -C 6 )alkyls.
7. The MOF or IRMOF of claim 1 , wherein at least one linking moiety comprises Formula I(a):
8. A MOF or IRMOF comprising the general structure M-L-M, wherein M comprises a metal and L is a linking moiety, and wherein at least one linking moiety comprises Formula IV(a):
9. The MOF or IRMOF of claim 1 , further comprising at least one linking moiety having Formula IV(a):
10. A MOF or IRMOF comprising the general structure M-L-M, wherein M comprises a metal and L is a linking moiety, and wherein at least one linking moiety comprises Formula IV(b):
wherein, y is a number from 0 to 20.
11. The MOF or IRMOF of claim 1 , further comprising at least one linking moiety having Formula IV(b):
wherein, y is a number from 0 to 20.
12. A method of making the MOF or IRMOF of claim 1 , comprising a reaction at an elevated temperature comprising a solvent, metal containing salt, and a linking moiety of Formula I:
wherein,
A 1 -A 8 are independently either N or C;
X 1 and X 2 are functional groups (FG);
R 1 and R 10 are hydroxyls;
R 2 -R 5 , R 7 , R 9 , R 11 and R 12 are hydrogen;
R 6 and R 8 are selected from the group consisting of (C 1 -C 12 )alkyl, (C 1 -C 12 )alkenyl, substituted (C 1 -C 12 )alkenyl, (C 1 -C 12 )alkynyl, substituted (C 1 -C 12 )alkynyl, hetero-(C 1 -C 12 )alkyl, substituted hetero-(C 1 -C 12 )alkyl, hetero-(C 1 -C 12 )alkenyl, substituted hetero-(C 1 -C 12 )alkenyl, hetero-(C 1 -C 12 )alkynyl, and substituted hetero-(C 1 -C 12 )alkynyl;
z is a number from 1 to 20; and
with the proviso that R is absent when bound to an A that is N.
13. A method of sorption of one or more chemicals from a solution, mixture, or suspension, comprising contacting the chemical with a MOF or IRMOF of claim 1 .
14. The method of claim 13 wherein the chemical is an organic molecule.
15. The method of claim 13 wherein the chemical is an inorganic molecule.
16. The method of claim 13 , wherein the MOF or IRMOF is disposed within a device.
17. The method of claim 16 , wherein the device is a column.
18. A MOF or IRMOF separation system for separating one or more chemicals from a multi-chemical solution, mixture, or suspension, comprising a flow chamber comprising an inlet and an outlet and a MOF or IRMOF of claim 1 disposed within the flow chamber between the inlet and outlet.
19. A MOF or IRMOF drug delivery device comprising a MOF or IRMOF of claim 1 and a pharmaceutically active agent.